Premium Industrial News

Human Growth Hormone Injections Annual Sales in China Less Than $1 Billion

Human Growth Hormone Injections Annual Sales in China Less Than $1 Billion

pharmaceutical

Industry Segment: Pharmaceutical & Biotech | Word Count: 184 Words

BEIJING--November 22, 2021--Researched by Industrial Info Resources (Sugar Land, Texas)--At present, China's domestic human growth hormone (hGH) mainly includes water and powder injections. Aqueous injection formulations have certain advantages in terms of drug activity and stability, and they are the main variety on the market. IIR is now tracking 42 active injections projects in China, worth US$3.15 billion.

This Premium Article can be purchased individually or as part of a subscription

Subscribe Now!(All Fields Required)

Subscription Type:

  • Pay-Per-Article - $5.95
  • Annual Premium News Subscription - $365.00
Pricing Help?